West Haven, CT1 Active Studies

Myalgic Encephalomyelitis Clinical Trials in West Haven, CT

Find 1 actively recruiting myalgic encephalomyelitis clinical trials in West Haven, CT. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
20,000
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in West Haven

About Myalgic Encephalomyelitis Clinical Trials in West Haven

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 1 myalgic encephalomyelitis clinical trials recruiting participants in West Haven, CT. These studies are seeking a combined 20,000 participants. Research is being sponsored by Duke University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in West Haven — FAQ

Are there myalgic encephalomyelitis clinical trials in West Haven?

Yes, there are 1 myalgic encephalomyelitis clinical trials currently recruiting in West Haven, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in West Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the West Haven research site will contact you about next steps.

Are clinical trials in West Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many West Haven studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 1 active trials in West Haven are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 22, 2026 from ClinicalTrials.gov